Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.
Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.
Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs
Timely Host Response Diagnostics for SEPSIS and Pneumonia
*The Nanōmix eLab® S1 Panel for Critical Infection has received CE Mark; other assays in development and regulatory review.
Nanōmix announced the appointment of Dr. Thomas Schlumpberger as Chief Executive Officer and as a member of the Board of Directors, effective immediately.
Biotron will market and distribute the Nanōmix eLab® system in Israel including the Nanomix S1 Panel cartridge and future new product cartridges for the eLab® system.
Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.
Study incorporates the use of the Nanōmix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain
IVDR certification enables Nanōmix to market its eLab® analyzer in the European Union under the newly established regulatory guidelines
